Skip to main content

Maureen B. Josephson, DO

Maureen B. Josephson, DO

Maureen B. Josephson, DO

Maureen B. Josephson, DO, is a pediatric pulmonologist and Medical Director of the Lung and Heart/Lung Transplant Programs at Children's Hospital of Philadelphia.


267-426-0664

About Maureen B. Josephson, DO

Titles

Attending Pulmonologist

Assistant Professor of Clinical Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Certifications

Pediatric Pulmonology – American Board of Pediatrics

Pediatrics – American Board of Pediatrics

Awards and Honors

2022, SJ Mag's Top Docs in Pulmonology
2011, American Thoracic Society Fellows Track Symposium, Travel Scholarship Recipient
2011, American College of Chest Physicians Pediatric Pulmonary and Critical Care Fellows Conference, Travel Scholarship Recipient
2011, Jacqueline E. Swartz Endowed Fellowship in Pediatric Pulmonology

Leadership and Memberships

International

2016-present, International Society of Heart and Lung Transplantation (ISHLT)

National

2020-Present, United Network for Organ Sharing (Lung Review Board Member
2009-Present, American Thoracic Society
2009-present, American College of Chest Physicians
2006-present, American Academy of Pediatrics (AAP)
2002-present, American Osteopathic Association

Editorial and Academic Positions

2016-present, Reviewer, Pediatric Transplantation

Education & training

Medical Degree

DO - University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford, NJ

Residency

Pediatrics - Schneider Children's Hospital at North Shore Long Island Jewish, New Hyde Park, NY

Fellowship

Pediatric Pulmonary and Sleep Medicine - Children's Hospital of Philadelphia, Philadelphia, PA

Additional Training

AmeriSpan SALUD Medical Spanish Program, Salamanca, Spain
BLS, PALS, NRP Certified

Publications

Publications

2019

Dean T, McDonough JM, Josephson M, Ginsberg JP, Carlson CA, Fiorino EK, Goldfarb SB.: Thoracic growth deficiency in childhood cancer survivors may cause overestimation of lung disease. Pediatric Pulmonology 54(10): 1602-1609, October 2019.

2015

Hu A, Diener BL, Josephson MB, Grunstein MM: Constitutively active signaling by the G protein βγ-subunit mediates intrinsically increased phosphodiesterase-4 activity in human asthmatic airway smooth muscle cells. Plos One 10(3): e0118712, March 2015 Notes: http://dx.doi.org/ 10.1371/journal.pone.0118712

2013

Hu Aihua, Josephson Maureen B, Diener Barry L, Nino Gustavo, Xu Shuyun, Paranjape Chinmay, Orange Jordan S, Grunstein Michael M: Pro-asthmatic cytokines regulate unliganded and ligand-dependent glucocorticoid receptor signaling in airway smooth muscle. PloS one 8(4): e60452, 2013. PMCID: PMC3617099

2012

Josephson Maureen B, Jiao Junfang, Xu Shuyun, Hu Aihua, Paranjape Chinmay, Grunstein Judith S, Grumbach Yael, Nino Gustavo, Kreiger Portia A, McDonough Joseph, Grunstein Michael M: IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response. American journal of physiology. Lung cellular and molecular physiology 303(5): L382-90, Sep 2012. PMCID: PMC3468426

Nino Gustavo, Hu Aihua, Grunstein Judith S, McDonough Joseph, Kreiger Portia A, Josephson Maureen B, Choi John K, Grunstein Michael M: G Protein βγ-subunit signaling mediates airway hyperresponsiveness and inflammation in allergic asthma. PloS one 7(2): e32078, 2012. PMCID: PMC3284547

Lectures by Invitation

2019

"Pulmonary Aspects of Cystic Fibrosis", The American Austrian Foundation, Salzburg, Austria

"Non-Pulmonary Aspects of Cystic Fibrosis", The American Austrian Foundation, Salzburg, Austria

"Clinical Trials- The Essentials", The American Austrian Foundation, Salzburg, Austria

2018

"Infants/child/Lung Transplant", lecture given at Neonatology Grand Rounds at Capital Health in Hopewell NJ

2015

Josephson MB. Community Acquired Pneumonia: When to Order What? Presented at: American Academy of Pediatrics; 2015 Oct; Washington DC.

Josephson MB. Cystic Fibrosis: An update on clinical and genetic aspects. Grandview Hospital; 2015 Oct; Sellersville PA.

Josephson MB. Interpreting genetic testing in PCD patients. PCD On the Move Clinical Conference; 2015 Aug; Minneapolis MN.

Books

2020

Cassandra Aravelo and Maureen Banfe Josephson: Book Title: Diagnostic and Interventional Bronchoscopy in ChildrenChapter Title: Flexible Bronchoscopy and Children's Interstitial Lung Disease. Respiratory Medicine. Springer Nature Switzerland, 2020.

2019

Ambika G. Chidambaram Maureen Josephson: Clinical research study designs: The essentials. Pediatric Investigation 3(4): 245-252, December 2019.

2018

Shapiro AJ, Davis SD, Polineni D, Manion M, Rosenfeld M, Dell SD, Chilvers MA, Ferkol TW, Zariwala MA, Sagel SD, Josephson M, Morgan L, Yilmaz O, Olivier KN, Milla C, Pittman JE, Daniels MLA, Jones MH, Janahi IA, Ware SM, Daniel SJ, Cooper ML, Nogee LM, Anton B, Eastvold T, Ehrne L, Guadagno E, Knowles MR, Leigh MW, Lavergne V; American Thoracic Society Assembly on Pediatrics.: Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine 197(1): e24- e39, June 2018.

Josephson M, Benden C, Hanna B: Solid Organ Transplantation in Infants and Children: Indications for lung transplantation. Organ and Tissue Transplantation Book Series Springer, 2018 Notes: Book chapter.

2017

Shapiro A, Josephson M, Rosenfeld M, Yilmaz O, Davis S, Polineni D, Guadagno E, Leigh M, Lavergne V: Accuracy of nasal nitric oxide as a diagnostic test for primary ciliary dyskinesia: A systematic review and metaanalysis. Annals of the American Thoracic Society 14(7): 1184-1196, July 2017.

2015

Goldfarb SB, Josephson M. Cystic Fibrosis. BMJ Best Practice 2015.

Goldfarb SB, Josephson M. Cystic Fibrosis. BMJ Point-of-Care 2015.

Patient experience rating

(based on 62 submissions)

  • Clear Explanation
    4.9 of 5
  • Showed Concern
    4.9 of 5
  • Included in decisions
    4.9 of 5
  • Would recommend
    4.9 of 5
  • Discussion of Proposed Treatment
    4.9 of 5
Learn about the patient experience rating system

About the Patient Experience Rating System

The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient’s protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.

Jump back to top